Profile data is unavailable for this security.
About the company
Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).
- Revenue in USD (TTM)356.70m
- Net income in USD-543.75m
- Incorporated2006
- Employees879.00
- LocationAscendis Pharma A/STuborg Boulevard 12HELLERUP 2900DenmarkDNK
- Phone+45 70222244
- Websitehttps://ascendispharma.dk/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revolution Medicines Inc | 4.57m | -484.27m | 6.32bn | 411.00 | -- | 3.66 | -- | 1,385.00 | -3.76 | -3.76 | 0.035 | 10.46 | 0.0031 | -- | 2.29 | 12,079.37 | -32.48 | -29.76 | -34.18 | -32.59 | -- | -- | -10,606.04 | -606.93 | -- | -- | 0.00 | -- | -67.27 | -10.50 | -75.46 | -- | 38.82 | -- |
Blueprint Medicines Corp | 282.21m | -288.29m | 6.61bn | 645.00 | -- | 21.27 | -- | 23.42 | -4.82 | -4.82 | 4.59 | 4.96 | 0.2499 | 0.3531 | 6.18 | 430,853.40 | -25.53 | -29.92 | -30.68 | -34.06 | 96.97 | -- | -102.15 | -116.65 | 3.61 | -23.37 | 0.4352 | -- | 22.22 | 41.14 | 9.06 | -- | 4.85 | -- |
Jazz Pharmaceuticals PLC | 3.84bn | 330.79m | 6.63bn | 2.80k | 21.71 | 1.79 | 6.78 | 1.73 | 4.85 | 4.85 | 55.49 | 58.65 | 0.3436 | 0.6428 | 5.78 | 1,372,634.00 | 2.99 | 1.48 | 3.36 | 1.62 | 89.53 | 88.79 | 8.69 | 4.26 | 1.90 | 1.87 | 0.607 | 0.00 | 4.78 | 15.19 | 285.14 | -1.49 | -20.04 | -- |
Viking Therapeutics Inc | 0.00 | -93.72m | 6.87bn | 28.00 | -- | 7.35 | -- | -- | -0.9305 | -0.9305 | 0.00 | 8.47 | 0.00 | -- | -- | 0.00 | -16.76 | -21.91 | -17.52 | -23.04 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -24.73 | -- | -- | -- |
Intra-Cellular Therapies Inc | 513.93m | -110.87m | 7.10bn | 610.00 | -- | 10.93 | -- | 13.81 | -1.15 | -1.15 | 5.34 | 6.15 | 0.6996 | 1.67 | 4.83 | 842,508.20 | -15.09 | -38.27 | -17.67 | -42.77 | 92.82 | -- | -21.57 | -128.42 | 5.00 | -- | 0.00 | -- | 85.51 | -- | 45.49 | -- | -7.22 | -- |
Legend Biotech Corp (ADR) | 342.80m | -465.95m | 7.29bn | 1.80k | -- | 6.27 | -- | 21.28 | -2.60 | -2.60 | 1.90 | 6.39 | 0.2297 | 9.52 | 203.86 | 190,443.30 | -31.22 | -37.71 | -37.33 | -47.19 | 52.35 | -- | -135.92 | -286.51 | 5.57 | -24.44 | 0.2233 | -- | 143.70 | 42.15 | -16.11 | -- | 1.57 | -- |
Cerevel Therapeutics Holdings Inc | 0.00 | -460.47m | 7.42bn | 355.00 | -- | 13.13 | -- | -- | -2.72 | -2.72 | 0.00 | 3.10 | 0.00 | -- | -- | 0.00 | -44.76 | -- | -48.20 | -- | -- | -- | -- | -- | -- | -- | 0.3745 | -- | -- | -- | -23.14 | -- | -- | -- |
Bellring Brands Inc | 1.84bn | 191.50m | 7.59bn | 420.00 | 40.45 | -- | 32.08 | 4.12 | 1.44 | 1.44 | 13.84 | -1.90 | 2.40 | 5.40 | 8.71 | 4,389,286.00 | 24.91 | 18.89 | 31.72 | -- | 32.74 | 32.44 | 10.39 | 10.10 | 1.84 | 5.07 | 1.42 | 0.00 | 21.53 | 15.03 | 101.09 | 13.80 | -18.48 | -- |
Vaxcyte Inc | 0.00 | -436.82m | 7.65bn | 254.00 | -- | 3.85 | -- | -- | -4.22 | -4.22 | 0.00 | 18.24 | 0.00 | -- | -- | 0.00 | -28.19 | -34.22 | -29.52 | -37.21 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -80.00 | -- | 107.28 | -- |
Roivant Sciences Ltd | 124.80m | 4.35bn | 7.65bn | 845.00 | 2.04 | 1.40 | 1.80 | 61.33 | 5.07 | 5.07 | 0.1571 | 7.40 | 0.026 | 0.8187 | 2.97 | 147,686.40 | 88.04 | -- | 103.92 | -- | 87.53 | -- | 3,390.53 | -- | 25.10 | -- | 0.0642 | -- | 103.65 | -- | 487.06 | -- | -- | -- |
Ascendis Pharma A/S (ADR) | 356.70m | -543.75m | 7.87bn | 879.00 | -- | -- | -- | 22.05 | -9.63 | -9.63 | 6.31 | -4.43 | 0.372 | 0.2469 | 11.50 | 405,796.80 | -56.71 | -47.35 | -130.03 | -53.29 | 85.61 | -- | -152.44 | -602.66 | 0.540 | -2.73 | 1.55 | -- | 421.20 | 90.68 | 17.45 | -- | -1.61 | -- |
Repligen Corp | 607.45m | 14.84m | 8.33bn | 1.78k | 590.64 | 4.22 | 98.63 | 13.71 | 0.2524 | 0.2524 | 10.74 | 35.29 | 0.2255 | 1.43 | 4.87 | 340,689.80 | 0.551 | 4.38 | 0.6179 | 5.03 | 47.73 | 55.43 | 2.44 | 15.91 | 5.24 | -- | 0.2284 | 0.00 | -20.31 | 26.91 | -77.64 | 20.13 | 24.99 | -- |
Exact Sciences Corp | 2.53bn | -240.23m | 8.39bn | 6.50k | -- | 2.67 | -- | 3.31 | -1.32 | -1.32 | 13.93 | 17.04 | 0.3998 | 5.28 | 11.96 | 389,975.40 | -3.79 | -9.71 | -4.13 | -10.60 | 73.67 | 74.10 | -9.48 | -28.21 | 1.45 | -- | 0.4323 | -- | 19.93 | 40.63 | 67.26 | -- | -3.71 | -- |
Elanco Animal Health Inc | 4.37bn | -1.30bn | 8.74bn | 9.30k | -- | 1.44 | -- | 2.00 | -2.64 | -2.64 | 8.84 | 12.26 | 0.2931 | 1.21 | 4.28 | 469,354.80 | -8.74 | -3.27 | -9.65 | -3.65 | 55.28 | 54.28 | -29.83 | -11.53 | 1.96 | 0.853 | 0.4877 | -- | 0.136 | 7.57 | -1,478.21 | -- | 2.74 | -- |
KBR Inc | 7.07bn | -258.00m | 8.82bn | 34.00k | -- | 6.28 | -- | 1.25 | -1.91 | -1.91 | 52.67 | 10.46 | 1.25 | -- | 5.56 | 207,970.60 | -4.45 | 0.4725 | -6.46 | 0.6678 | 13.86 | 12.18 | -3.58 | 0.4122 | -- | 1.17 | 0.5678 | 340.00 | 5.97 | 7.20 | -240.21 | -- | 36.31 | 11.03 |
Insmed Inc | 315.49m | -746.89m | 8.98bn | 912.00 | -- | -- | -- | 28.45 | -5.23 | -5.23 | 2.20 | -3.13 | 0.2357 | 0.8971 | 9.32 | 345,936.40 | -55.80 | -40.96 | -72.23 | -46.88 | 78.07 | 77.99 | -236.74 | -212.92 | 1.61 | -16.08 | 1.64 | -- | 24.39 | 98.78 | -55.66 | -- | -2.15 | -- |
Holder | Shares | % Held |
---|---|---|
RA Capital Management LPas of 31 Mar 2024 | 10.11m | 17.52% |
Artisan Partners LPas of 31 Mar 2024 | 5.67m | 9.83% |
Fidelity Management & Research Co. LLCas of 31 Mar 2024 | 4.61m | 7.99% |
Westfield Capital Management Co. LPas of 31 Mar 2024 | 4.08m | 7.06% |
Avoro Capital Advisor LLCas of 31 Mar 2024 | 3.97m | 6.87% |
Janus Henderson Investors US LLCas of 31 Mar 2024 | 3.70m | 6.42% |
Wellington Management Co. LLPas of 31 Mar 2024 | 2.75m | 4.76% |
T. Rowe Price Investment Management, Inc.as of 31 Mar 2024 | 2.57m | 4.45% |
Capital Research & Management Co. (International Investors)as of 31 Mar 2024 | 2.19m | 3.80% |
T. Rowe Price Associates, Inc. (Investment Management)as of 31 Mar 2024 | 1.78m | 3.09% |